InspireMD (NSPR) Share-based Compensation Growth (1y) (2011 - 2025)
InspireMD (NSPR) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -30.44% |
| 10 | InspireMD | 44.38 Mn | -9.83 Mn | 1.18 Mn | 21.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.40% |
| Sep 30, 2025 | 104.69% |
| Jun 30, 2025 | -89.10% |
| Mar 31, 2025 | 4.24% |
| Dec 31, 2024 | 42.27% |
| Sep 30, 2024 | -82.92% |
| Jun 30, 2024 | 7.53% |
| Mar 31, 2024 | 805.88% |
| Dec 31, 2023 | 348.10% |
| Sep 30, 2023 | 146.88% |
| Jun 30, 2023 | 37.98% |
| Mar 31, 2023 | -55.74% |
| Dec 31, 2022 | -34.98% |
| Sep 30, 2022 | 116.12% |
| Jun 30, 2022 | 75.98% |
| Mar 31, 2022 | 102.17% |
| Dec 31, 2021 | 64.06% |
| Sep 30, 2021 | 115.60% |
| Jun 30, 2021 | 650.98% |
| Mar 31, 2021 | 368.12% |